Suppr超能文献

应对阿片类药物使用的污名化问题。

Managing the stigma of opioid use.

作者信息

Stuart Heather

机构信息

1 Centre for Health Services and Policy Research, Queen's University, Kingston, Ontario, Canada.

出版信息

Healthc Manage Forum. 2019 Mar;32(2):78-83. doi: 10.1177/0840470418798658. Epub 2019 Jan 30.

Abstract

Substance use stigma makes it difficult to reframe the opioid crisis as a public health issue and has been a barrier to accessing life-saving treatments. Interventions using people that convey recovery stories are promising practices. Groups that may benefit from targeted stigma reduction interventions include opioid users (to combat shame and blame), at-risk youth, first responders, dispensary personal, media, and healthcare professionals. The evidence supporting antistigma interventions is thin, with little Canadian research. Research is needed to establish the effectiveness of substance-related stigma reduction strategies. Health leaders should examine their own responsibilities to lead the public health debate, reduce opioid-related stigma, and actively engage members of the community of those with lived experience to become partners in these activities.

摘要

药物使用污名化使得将阿片类药物危机重新界定为一个公共卫生问题变得困难,并且一直是获取挽救生命治疗的障碍。利用讲述康复故事的人进行的干预是很有前景的做法。可能从有针对性的减少污名化干预中受益的群体包括阿片类药物使用者(以对抗羞耻感和指责)、高危青少年、急救人员、药房工作人员、媒体和医疗保健专业人员。支持反污名化干预的证据不足,加拿大的相关研究很少。需要开展研究以确定减少与药物相关污名化策略的有效性。卫生领导人应审视自身在引领公共卫生辩论、减少与阿片类药物相关的污名化以及积极促使有实际经历的社区成员成为这些活动伙伴方面的责任。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验